C43 C44
Conditions
Interventions
Group 1: As part of routine care, the patients medical history is recorded before inclusion in the study. Known neurological diseases, such as dementia, the presence of brain tumors or the use of neur
this is done once). These test the personality structure, but above all the cognitive functions of the patient treated as part of routine care using system therapy (e.g. memory, executive ability).
Th
Sponsors
Universitätshautklinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: • Diagnosis of a tumor of the skin, mucous membrane and/or skin appendages OR • Diagnosis of uveal melanoma • Treatment at the study center • Signed consent form from the patient or his/her caregiver • First-line therapy for the melanoma
Exclusion criteria
Exclusion criteria: • Lack of consent form • Known brain metastases • Neurological diseases e.g. dementia • (Active) drug use • Current use of medication with proven cognitive impairment • Other cancer (second neoplasm) =2 years ago • (Second) systemic anti-tumor therapy e.g. chemotherapy or previous immunotherapy • Immunosuppression or immunodeficiency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive performance as measured by the tests used in the study | — |
Countries
Germany
Outcome results
None listed